To address this paucity, the Assessing the Dosage Pattern and Demographic Characteristics in Heart Failure Reduced Ejection Fraction Patients Initiated with Angiotensin Receptor-Neprilysin Inhibitor in India (ADD-ARNI) study was designed to characterize contemporary HFrEF pharmacotherapy in India. Here, MME is linked to heart failure.